Scientific Opinion on the substantiation of a health claim related to 3 g/day plant stanols as plant stanol esters and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 10, Issue 5, 2012, Pages

[No Author Info available]

Author keywords

coronary heart disease; LDL cholesterol; Plant stanols; plant sterols

Indexed keywords

EID: 85078395227     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2012.2692     Document Type: Article

References (25)

1. Alhassan, S.; Reese, K.A.; Mahurin, J.; Plaisance, E.P.; Hilson, B.D.; Garner, J.C.; Wee, S.O. and Grandjean, P.W., 2006. Blood lipid responses to plant stanol ester supplementation and aerobic exercise training. Metabolism: Clinical and Experimental 55, 541–549.
2. Blair, S.N.; Capuzzi, D.M.; Gottlieb, S.O.; Nguyen, T.; Morgan, J.M. and Cater, N.B., 2000. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am. J. Cardiol. 86, 46–52.
3. Cater, N.B.; Garcia-Garcia, A.B.; Vega, G.L. and Grundy, S.M., 2005. Responsiveness of plasma lipids and lipoproteins to plant stanol esters. Am. J. Cardiol. 96, 23D–28D.
4. Commission of the European Communities, 2004. Commission Regulation (EC) No 608/2004 of 31 March 2004 concerning the labelling of foods and food ingredients with added phytosterols, phytosterol esters, phytstanols and/or phytostanol esters. Off. J. Eur. Union 47, 44–45. Available at: eur-lex.europa.eu/LexUriServ/LexUriServ.do*uri=iJ:L:2004:097:0044:0045:EN:PDF.
5. Commission of the European Communities. 983/2009 of 21 October 2009 on the authorisation and refusal of authorisation of certain health claims made on food and referring to the reduction of disease risk and to children's development and health (Text with EEA relevance) [L277]. Off J Eur Communities 52, 3-12. Available at: eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=iJ:L:2009:277:0003:0012:EN:PDF.
6. Commission. Commission Regulation (EU) No 376/2010 of 3 May 2010 amending Regulation (EC) No 983/2009 on the authorisation and refusal of authorisation of certain health claims made on food and referring to the reduction of disease risk and to children's development and health (Text with EEA relevance) [L111]. Off J Eur Communities 53, 3-4. Available at: eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=iJ:L:2010:111:0003:0004:EN:PDF.
7. Demonty, I.; Ras, R.T.; van der Knaap, H.C.; Duchateau, G.S.; Meijer, L.; Zock P.L.; Geleijnse, J.M. and Trautwein, E.A., 2009. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake [plus supplemental data] J. Nutr. 139, 271–284.
8. EFSA (European Food Safety Authority), 2009. Scientific Opinion of the Panel on Dietetic Products Nutrition and Allergies on a request from the European Commission and a similar request from France in relation to the authorisation procedure for health claims on plant sterols/stanols and lowering/reducing blood LDL-cholesterol pursuant to Article 14 of Regulation (EC) No 1924/2006. The EFSA Journal (2009) 1175, 1–9.
9. Gylling, H. and Miettinen, T.A., 1994. Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholestrolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 37, 773–780.
10. Gylling, H. and Miettinen, T.A., 1996. Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin-dependent diabetic men. J. Lipid Res. 37, 1776–1785.
11. Gylling, H.; Radhakrishnan, R. and Miettinen, T.A., 1997. Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine. Women and dietary sitostanol. Circulation 96, 4226–4231.
12. Hallikainen, MA. and Uusitupa, M.I.J., 1999. Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am. J. Clin. Nutr. 69, 403–410.
13. Hallikainen, M.; Kurl, S.; Laakso, M.; Miettinen, T.A. and Gylling, H., 2011. Plant stanol esters lower LDL-cholesterol level in statin-treated subjects with type 1 diabetes by interfering the absorption and synthesis of cholesterol. Atherosclerosis [advance electronic publication, Apr. 5, 2011].
14. Hallikainen, M.; Miettinen, TA. and Gylling, H, 2010. (Unpublished Study report): Effects of Plant Stanol Esters on Serum Lipids, Precursors of Cholesterol Synthesis and Plant Sterols in Type 1 Diabetics on Stable Statin Drug Use: L. University of Kuopio, Institute of Public Health and Clinical Nutrition, Department of Clinical Nutrition, Helsinki, Finland, Clinical Trials Register # NCT01205308, Raisio study number: CL2009_019.
15. Homma Y, Ikeda I, Ishikawa T, Tateno M, Sugano M, Nakamura H. Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trial. Nutrition. (2003) 19;4:369–374.
16. Jones PJ, Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Feng JY, Parsons WE (2000). Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res 41 (5): 697–705.
17. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R, 2003. Stresa Workshop Participants, 2003. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin. Proc. 78, 965–978.
18. Mensink, R.P.; Ebbing, S.; Lindhout, M.; Plat, J. and van Heugten, M.M., 2002. Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations. Atherosclerosis 160, 205–213.
19. Mensink, R.P.; de Jong, A.; Lütjohann, D.; Haenen, G.R.M.M. and Plat, J., 2010. Plant stanols dose-dependently decrease LDL-cholesterol concentrations, but not cholesterol-standardized fat-soluble antioxidant concentrations, at intakes up to 9 g/d. Am. J. Clin. Nutr. 92, 24–33.
20. Miettinen, T.A.; Puska, P.; Gylling, H.; Vanhanen, H. and Vartiainen, E., 1995. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N. Engl. J. Med. 333, 1308–1312.
21. Nguyen, T.T.; Dale, L.C.; von Bergmann, K. and Croghan, I.T., 1999. Cholesterol-lowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial. Mayo Clin. Proc. 74, 1198–1206.
22. Noakes, M.; Clifton, P.M.; Doornbos, A.M. and Trautwein, E.A., 2005. Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects. Eur. J. Nutr. 44, 214–222.
23. Raisio, 2011. Article 14 Health Claim Application Pertaining to the daily consumption of 3 grams plant stanols (as plant stanol ester) and LDL-cholesterol reduction of 12%
24. Weststrate, J.A. and Meijer, G.W., 1998. Plant sterol-enriched margarines and reduction of plasma total- and LDL- cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 52, 334–343.
25. Musa-Veloso, K.; Poon, T.H.; Elliot, J.A. and Chung, C., 2011. A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results of a meta-analysis of randomized, placebo-controlled trials. Prostaglandins, Leukotrienes and Essential Fatty Acids [advance electronic publication, Feb. 21, 2011].